Sort
35,931 grants matching “parkinsons”
PERIPHERAL AND CENTRAL POSTURAL DISORDERS IN THE ELDERLY
$476,351Oregon Health And Science University · R01 · FY2002 · AG
Rechargeable Implantable Thin-Film Lithium Battery
$476,330Simon K Nieh · Front Edge Technology, Inc. · R44 · FY2010 · DC
Core--Ascertainment and Clinical
$476,285Duke University · P50 · FY2004 · NS
Core--Ascertainment and Clinical
$476,221Duke University · P50 · FY2005 · NS
Genetic Engineering of ES Cells towards Optimal Cell Transplantation for PD
$476,177Kwang-Soo Kim · Mclean Hospital · P50 · FY2008 · NS
Mechanisms associated with neuroprotection from Mn-induced neurotoxicity.
$476,082Eun Sook Yu Lee · Florida Agricultural And Mechanical Univ · R01 · FY2021 · ES
Assessment of Candidate Loci in Neurological diseases
$475,976Andrew Singleton · National Institute On Aging · ZIA · FY2014 · AG
A randomized trial of dance on mood, balance and brain in Alzheimer's Disease
$475,954Christina E Hugenschmidt · Wake Forest University Health Sciences · R01 · FY2017 · AT
Articulatory Kinematics in Neurogenic Speech Disorders
$475,952University Of Wisconsin Madison · R01 · FY2005 · DC
Deuterium metabolic imaging (DMI) of neurological disease
$475,924Robin A De Graaf · Yale University · R01 · FY2025 · EB
3D STRUCTURE/FUNCTION OF LIGAND GATED ION CHANNELS
$475,896Columbia University Health Sciences · R01 · FY2002 · NS
Unbiased Approaches to Novel Biomarker Discovery in Parkinson's Disease
$475,894Alice S Chen-Plotkin · University Of Pennsylvania · U01 · FY2012 · NS
Project ASSIST for Chronic Illness Caregivers
$475,886University Of Alabama At Birmingham · R01 · FY2002 · NR
Vesicular modulation of dopamine neuron toxicity
$475,682Gary W Miller · Columbia University Health Sciences · R01 · FY2025 · ES
Vesicular modulation of dopamine neuron toxicity
$475,682Gary W Miller · Columbia University Health Sciences · R01 · FY2024 · ES
Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease
$475,570Kiran Solingapuram Sai · Wake Forest University Health Sciences · R01 · FY2023 · AG
HDACs in Neurodegeneration and Aging
$475,565Lisa M. Ellerby · Buck Institute For Research On Aging · RL1 · FY2010 · NS
NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESENEUROTOXICITY
$475,542Susan Criswell · St. Joseph'S Hospital And Medical Center · R01 · FY2023 · ES
The pathophysiology of morning migraine
$475,475Agustin Melo Carrillo · Beth Israel Deaconess Medical Center · R21 · FY2025 · NS
VPS35 as a therapeutic target in Parkinson's disease
$475,475David K. Simon · Beth Israel Deaconess Medical Center · R21 · FY2023 · NS
USP30 Inhibition as a Therapeutic Strategy in Parkinson's Disease
$475,475David K. Simon · Beth Israel Deaconess Medical Center · R21 · FY2023 · NS
Propagation of Lewy pathology in Parkinson's and related disorders
$475,472Kelvin C Luk · University Of Pennsylvania · R01 · FY2021 · NS
Selenoprotein P function and regulation of expression
$475,450University Of Hawaii At Manoa · R01 · FY2005 · NS
PERIPHERAL AND CENTRAL POSTURAL DISORDERS IN THE ELDERLY
$475,410Oregon Health And Science University · R01 · FY2001 · AG
Short-Term Synaptic Plasticity in the CNS
$475,282Wade G Regehr · Harvard Medical School · R01 · FY2012 · NS